Multicenter Interventional Study Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature paediatric patients compared with daily growth hormone
Small for gestational age (SGA) and idiopathic short stature (ISS)
Investigational medicinal product(s)
GENOTROPIN 12 mg powder and solvent for solution for injection.Ngenla 60 mg solution for injection in pre-filled pen
Eligibility
Age group
0-17 years
Sex
Female, Male
Primary endpoint
Annualized HV after 12 months of treatment
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.